Management of lower limb deformities in children with osteogenesis imperfecta

被引:0
|
作者
Satvinder Kaur
Ketan Prasad Kulkarni
Inderpal Singh Kochar
Ramani Narasimhan
机构
[1] Apollo Center for Advanced Pediatrics,Department of Pediatrics
[2] Indraprastha Apollo Hospital,Department of Pediatric Endocrinology
[3] Apollo Center for Advanced Pediatrics,Department of Pediatric Orthopedics
[4] Indraprastha Apollo Hospital,undefined
[5] Apollo Center for Advanced Pediatrics,undefined
[6] Indraprastha Apollo Hospital,undefined
[7] Apollo Center for Advanced Pediatrics,undefined
来源
Indian Pediatrics | 2011年 / 48卷
关键词
Bisphosphonates; Deformities; Management; Osteogenesis imperfecta;
D O I
暂无
中图分类号
学科分类号
摘要
Osteogenesis imperfecta (OI) often leads to severe lower limb (LL) deformities due to recurrent fractures that significantly hamper ambulation. We describe our management experience of correction of LL deformities in four children with OI. Medical management consisted of peri and postoperative pamidronate therapy, calcium supplementation and rehabilitative care. Deformities were corrected with multiple osteotomies and intramedullary fixation by titanium elastic nails. At a mean follow-up of 30 months, all children have significantly reduced fracture incidence and have no evidence of recurrence of deformities with improved ambulatory status. We emphasize the importance of combined medical and surgical therapy for these patients.
引用
收藏
页码:637 / 639
页数:2
相关论文
共 50 条
  • [31] Osteogenesis imperfecta
    Glorieux, Francis H.
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2008, 22 (01): : 85 - 100
  • [32] Osteogenesis imperfecta
    Chan, E.
    DeVile, C.
    Ratnamma, V. S.
    BJA EDUCATION, 2023, 23 (05) : 182 - 188
  • [33] Wirbelkörperkompressionen bei Osteogenesis imperfecta Wirksamkeit der i.v. Neridronattherapie bei Kindern und JugendlichenVertebral deformities in osteogenesis imperfecta Effects of i.v. neridronate therapy in children and adolescents
    R. Beccard
    O. Fricke
    C. Land
    O. Semler
    F. Körber
    A. Stabrey
    E. Schönau
    Monatsschrift Kinderheilkunde, 2009, 157 : 1237 - 1241
  • [34] Surgical management of long bone pseudarthrosis with severe limb length discrepancy in osteogenesis imperfecta
    To, Michael
    Gupta, Vikas
    Chow, Wang
    JOURNAL OF PEDIATRIC ORTHOPAEDICS-PART B, 2013, 22 (01): : 63 - 69
  • [35] Serum creatine kinase isoenzymes in children with osteogenesis imperfecta
    P. D’Eufemia
    R. Finocchiaro
    A. Zambrano
    V. Lodato
    L. Celli
    S. Finocchiaro
    P. Persiani
    A. Turchetti
    M. Celli
    Osteoporosis International, 2017, 28 : 339 - 346
  • [36] Benefit of infusions with ibandronate treatment in children with osteogenesis imperfecta
    Li Mei
    Xia Wei-bo
    Xing Xiao-ping
    Yu Wei
    Hu Ying-ying
    Jiang Yan
    Wang Ou
    Liu Hai-juan
    Han Lan-wen
    Meng Xun-wu
    Xu Ling
    CHINESE MEDICAL JOURNAL, 2011, 124 (19) : 3049 - 3053
  • [37] Zoledronic acid (zoledronate) in children with osteogenesis imperfecta (OI)
    Maria Sanchez-Sanchez, Luz
    Uriel Cabrera-Pedroza, Alfredo
    Palacios-Saucedo, Gerardo
    GACETA MEDICA DE MEXICO, 2015, 151 (02): : 164 - 168
  • [38] Osteogenesis imperfecta in Cameroonese children.
    Amvene, SN
    Obama, MTA
    Amana, JP
    Kobela, M
    Takongmo, S
    Andze, GO
    Mbede, J
    ANNALES DE PEDIATRIE, 1997, 44 (04): : 279 - 282
  • [39] Echocardiographic study in children with osteogenesis imperfecta
    Pinheiro, Bruna S.
    Barrios, Patricia M.
    Souza, Liliane T.
    Felix, Temis M.
    CARDIOLOGY IN THE YOUNG, 2020, 30 (10) : 1490 - 1495
  • [40] Hearing loss in children with osteogenesis imperfecta
    Kuurila, K
    Grénman, R
    Johansson, R
    Kaitila, I
    EUROPEAN JOURNAL OF PEDIATRICS, 2000, 159 (07) : 515 - 519